Ruste, Celsa .

HRN: 05-69-02  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/23/2026
04/30/2026
IV
600
Q6
Infected Breast Mass
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: